Michael Harsh
CIK: 0001706155
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NDRA
ENDRA Life Sciences Inc.
Director
Discretionary Trading P&L
Holdings
About Harsh Michael
Harsh Michael (SEC CIK 0001706155) files insider reports with the SEC as Director of ENDRA Life Sciences Inc. (NDRA).
Signal8 holds 2 ownership filings by Harsh Michael, all Form 4s, filed between Jul 1, 2025 and Jan 23, 2026. Those filings report 2 transactions, from Jun 11, 2025 to Jan 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Harsh Michael's filings is in ANN ARBOR, MI.
Recent filings by Harsh Michael
Other insiders filing for ENDRA Life Sciences Inc. (NDRA)
- ASP Isotopes Inc., 10% Owner
- Tokman Alexander Y, Chief Executive Officer
- Jacroux Richard, Chief Financial Officer
- DIGIANDOMENICO ANTHONY, Director
- Basenese Lou, Director
- UBS Group AG, Officer